Search
for
Sort by
Research 541–570 of 882
- Skin Graft Harvesting and Donor Site Selection
- Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia Areata
- Alopecia Areata Treatment Patterns and Satisfaction: Results of a Real-World Cross-Sectional Survey in Europe
- Unilateral Straight Hair—A Symptom of Acquired Horner's Syndrome in a Neonate
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata
- The demographic and clinical profile of patients with alopecia areata in Syria: A study letter
- Janus Kinase inhibitors in dermatology: a review
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- Why Do Not All Chemotherapy Patients Lose Their Hair? Answering an Intriguing Question
- Trichoscopic Findings of Frontal Fibrosing Alopecia
- Bitemporal alopecia areata
- Skin transcriptome reveals the Periodic changes in genes underlying hair follicle cycling in Cashmere goats
- Acne scars: Classification and treatment
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Utilization of a Combination of Papaya (Carica papaya L.) Seed Oil and Virgin Coconut Oil (VCO) in Pomade Formulation and Its Effectiveness Test
- DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT
- People’s experiences of eyebrow transplantation: A qualitative study
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Case Report: Secondary syphilitic alopecia following non-penetrative sexual contact: a case of initial misdiagnosis
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Managing androgenic alopecia with individualised homeopathic medicine and biochemic remedies- An evidence based single case report
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Long-Term Multimodal Reconstruction of Extensive Post-Burn Scalp Alopecia Using Tissue Expansion and Follicular Unit Extraction: A 10-Year Follow-Up Case Report
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- Hair for the Long Haul: Alopecia Areata Cases and Considerations
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Baricitinib Provides Significant Hair Regrowth In Adolescents With Severe Alopecia Areata: 52-Week Efficacy and Safety Results From A Phase 3 Randomized, Controlled Trial